Emily Smyth PharmD

Emily Nash Smyth, PharmD is a Principal Research Scientist at Eli Lilly and Company. She joined Lilly in 2001 as a Visiting Scientist Fellow following the completion of her Bachelor and Science degree in Pharmacy from The Ohio State University and her Doctor of Pharmacy degree from the University of Cincinnati. She has spent most of her nearly 22-year career in oncology in scientific and leadership roles in both Medical Affairs as well as the Value, Evidence, and Outcomes organization. Her work in nearly the last 15 years in outcomes research has spanned early and late phase drug development. In her current role, she is a strategic partner within development teams. She partners globally with cross-functional partners to develop real-world evidence (RWE) that informs clinical development strategies and the understanding of how patients with cancer are treated in routine clinical practice. In addition to RWE, Emily leads the economic value strategy for the area she supports, including dossier and model development for new and existing medicines.